Dermal and transdermal delivery of protein pharmaceuticals: lipid-based delivery systems for interferon α

The dermal and transdermal delivery of protein pharmaceuticals faces enormous challenges, and at the same time has very significant potential for the non‐invasive treatment of both localized and systemic diseases. In this article we review the various approaches used to enhance and control the deliv...

Full description

Saved in:
Bibliographic Details
Published in:Biotechnology and applied biochemistry 1999-10, Vol.30 (2), p.129-137
Main Authors: Foldvari, Marianna, Baca-Estrada, Maria E., He, Zhihong, Hu, Jiaping, Attah-Poku, Samuel, King, Martin
Format: Article
Language:English
Subjects:
a-Interferon
Acetylation
Administration, Cutaneous
Administration, Topical
Biological and medical sciences
Biotechnology
Drug Carriers
Drug Delivery Systems
Fundamental and applied biological sciences. Psychology
Health. Pharmaceutical industry
Humans
Industrial applications and implications. Economical aspects
Interferon-alpha - administration & dosage
Interferon-alpha - chemistry
Interferon-alpha - pharmacokinetics
Liposomes
Miscellaneous
Skin Absorption
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4683-48f1dedafb22446b82eae555848a15d969db037004922cf4517cfef1e562d7413
cites cdi_FETCH-LOGICAL-c4683-48f1dedafb22446b82eae555848a15d969db037004922cf4517cfef1e562d7413
container_end_page 137
container_issue 2
container_start_page 129
container_title Biotechnology and applied biochemistry
container_volume 30
creator Foldvari, Marianna
Baca-Estrada, Maria E.
He, Zhihong
Hu, Jiaping
Attah-Poku, Samuel
King, Martin
description The dermal and transdermal delivery of protein pharmaceuticals faces enormous challenges, and at the same time has very significant potential for the non‐invasive treatment of both localized and systemic diseases. In this article we review the various approaches used to enhance and control the delivery of protein therapeutic agents through the dermal barrier. We show results of the delivery of interferon (IFN) α, an antiviral agent used in the treatment of condylomata acuminata (genital warts), using lipid‐based delivery systems (LBDS). In the general category of LBDS, we investigated the use of liposomes and fatty acylation as ways to increase IFNα delivery into human skin.
doi_str_mv 10.1111/j.1470-8744.1999.tb00903.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70832888</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17405084</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4683-48f1dedafb22446b82eae555848a15d969db037004922cf4517cfef1e562d7413</originalsourceid><addsrcrecordid>eNqVkd9uFCEUxonR2G31FQwxxrsZgYEBemHSbrUaG038E70jzHCIrPNnhdm6-1i-iM8k62xa74zcADm_7-NwPoQeU1LSvJ6tSsolKZTkvKRa63JqCNGkKrd30OKmdBctiFKi4IJWR-g4pRUhREnF7qMjSgRlUrMFWl1A7G2H7eDwFO2Q3Hx30IVriDs8eryO4wRhwOuvNtda2EyhtV06xV1YB1c0NoG7FaRdmqBP2I8Rh2GC6CGOA_718wG657MMHh72E_Tp5YuPy1fF1bvL18uzq6LltaoKrjx14KxvGOO8bhQDC0IIxZWlwulau4ZUkhCuGWt9_p5sPXgKomZOclqdoKezb-77-wbSZPqQWug6O8C4SUYSVTGl1D9BKjkRRPEMns5gG8eUInizjqG3cWcoMftIzMrs5272czf7SMwhErPN4keHVzZND-4v6ZxBBp4cAJvyXH1OoQ3pltOa1X-w5zP2I3Sw-48OzPnZeT5kg2I2CDmg7Y2Bjd9MLSspzOe3l-bD-yWR1cUb86X6DTHpuZc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17405084</pqid></control><display><type>article</type><title>Dermal and transdermal delivery of protein pharmaceuticals: lipid-based delivery systems for interferon α</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Foldvari, Marianna ; Baca-Estrada, Maria E. ; He, Zhihong ; Hu, Jiaping ; Attah-Poku, Samuel ; King, Martin</creator><creatorcontrib>Foldvari, Marianna ; Baca-Estrada, Maria E. ; He, Zhihong ; Hu, Jiaping ; Attah-Poku, Samuel ; King, Martin</creatorcontrib><description>The dermal and transdermal delivery of protein pharmaceuticals faces enormous challenges, and at the same time has very significant potential for the non‐invasive treatment of both localized and systemic diseases. In this article we review the various approaches used to enhance and control the delivery of protein therapeutic agents through the dermal barrier. We show results of the delivery of interferon (IFN) α, an antiviral agent used in the treatment of condylomata acuminata (genital warts), using lipid‐based delivery systems (LBDS). In the general category of LBDS, we investigated the use of liposomes and fatty acylation as ways to increase IFNα delivery into human skin.</description><identifier>ISSN: 0885-4513</identifier><identifier>EISSN: 1470-8744</identifier><identifier>DOI: 10.1111/j.1470-8744.1999.tb00903.x</identifier><identifier>PMID: 10512792</identifier><identifier>CODEN: BABIEC</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>a-Interferon ; Acetylation ; Administration, Cutaneous ; Administration, Topical ; Biological and medical sciences ; Biotechnology ; Drug Carriers ; Drug Delivery Systems ; Fundamental and applied biological sciences. Psychology ; Health. Pharmaceutical industry ; Humans ; Industrial applications and implications. Economical aspects ; Interferon-alpha - administration &amp; dosage ; Interferon-alpha - chemistry ; Interferon-alpha - pharmacokinetics ; Liposomes ; Miscellaneous ; Skin Absorption</subject><ispartof>Biotechnology and applied biochemistry, 1999-10, Vol.30 (2), p.129-137</ispartof><rights>1999 International Union of Biochemistry and Molecular Biology</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4683-48f1dedafb22446b82eae555848a15d969db037004922cf4517cfef1e562d7413</citedby><cites>FETCH-LOGICAL-c4683-48f1dedafb22446b82eae555848a15d969db037004922cf4517cfef1e562d7413</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1992692$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10512792$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Foldvari, Marianna</creatorcontrib><creatorcontrib>Baca-Estrada, Maria E.</creatorcontrib><creatorcontrib>He, Zhihong</creatorcontrib><creatorcontrib>Hu, Jiaping</creatorcontrib><creatorcontrib>Attah-Poku, Samuel</creatorcontrib><creatorcontrib>King, Martin</creatorcontrib><title>Dermal and transdermal delivery of protein pharmaceuticals: lipid-based delivery systems for interferon α</title><title>Biotechnology and applied biochemistry</title><addtitle>Biotechnol Appl Biochem</addtitle><description>The dermal and transdermal delivery of protein pharmaceuticals faces enormous challenges, and at the same time has very significant potential for the non‐invasive treatment of both localized and systemic diseases. In this article we review the various approaches used to enhance and control the delivery of protein therapeutic agents through the dermal barrier. We show results of the delivery of interferon (IFN) α, an antiviral agent used in the treatment of condylomata acuminata (genital warts), using lipid‐based delivery systems (LBDS). In the general category of LBDS, we investigated the use of liposomes and fatty acylation as ways to increase IFNα delivery into human skin.</description><subject>a-Interferon</subject><subject>Acetylation</subject><subject>Administration, Cutaneous</subject><subject>Administration, Topical</subject><subject>Biological and medical sciences</subject><subject>Biotechnology</subject><subject>Drug Carriers</subject><subject>Drug Delivery Systems</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Health. Pharmaceutical industry</subject><subject>Humans</subject><subject>Industrial applications and implications. Economical aspects</subject><subject>Interferon-alpha - administration &amp; dosage</subject><subject>Interferon-alpha - chemistry</subject><subject>Interferon-alpha - pharmacokinetics</subject><subject>Liposomes</subject><subject>Miscellaneous</subject><subject>Skin Absorption</subject><issn>0885-4513</issn><issn>1470-8744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNqVkd9uFCEUxonR2G31FQwxxrsZgYEBemHSbrUaG038E70jzHCIrPNnhdm6-1i-iM8k62xa74zcADm_7-NwPoQeU1LSvJ6tSsolKZTkvKRa63JqCNGkKrd30OKmdBctiFKi4IJWR-g4pRUhREnF7qMjSgRlUrMFWl1A7G2H7eDwFO2Q3Hx30IVriDs8eryO4wRhwOuvNtda2EyhtV06xV1YB1c0NoG7FaRdmqBP2I8Rh2GC6CGOA_718wG657MMHh72E_Tp5YuPy1fF1bvL18uzq6LltaoKrjx14KxvGOO8bhQDC0IIxZWlwulau4ZUkhCuGWt9_p5sPXgKomZOclqdoKezb-77-wbSZPqQWug6O8C4SUYSVTGl1D9BKjkRRPEMns5gG8eUInizjqG3cWcoMftIzMrs5272czf7SMwhErPN4keHVzZND-4v6ZxBBp4cAJvyXH1OoQ3pltOa1X-w5zP2I3Sw-48OzPnZeT5kg2I2CDmg7Y2Bjd9MLSspzOe3l-bD-yWR1cUb86X6DTHpuZc</recordid><startdate>199910</startdate><enddate>199910</enddate><creator>Foldvari, Marianna</creator><creator>Baca-Estrada, Maria E.</creator><creator>He, Zhihong</creator><creator>Hu, Jiaping</creator><creator>Attah-Poku, Samuel</creator><creator>King, Martin</creator><general>Blackwell Publishing Ltd</general><general>Portland Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>199910</creationdate><title>Dermal and transdermal delivery of protein pharmaceuticals: lipid-based delivery systems for interferon α</title><author>Foldvari, Marianna ; Baca-Estrada, Maria E. ; He, Zhihong ; Hu, Jiaping ; Attah-Poku, Samuel ; King, Martin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4683-48f1dedafb22446b82eae555848a15d969db037004922cf4517cfef1e562d7413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>a-Interferon</topic><topic>Acetylation</topic><topic>Administration, Cutaneous</topic><topic>Administration, Topical</topic><topic>Biological and medical sciences</topic><topic>Biotechnology</topic><topic>Drug Carriers</topic><topic>Drug Delivery Systems</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Health. Pharmaceutical industry</topic><topic>Humans</topic><topic>Industrial applications and implications. Economical aspects</topic><topic>Interferon-alpha - administration &amp; dosage</topic><topic>Interferon-alpha - chemistry</topic><topic>Interferon-alpha - pharmacokinetics</topic><topic>Liposomes</topic><topic>Miscellaneous</topic><topic>Skin Absorption</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Foldvari, Marianna</creatorcontrib><creatorcontrib>Baca-Estrada, Maria E.</creatorcontrib><creatorcontrib>He, Zhihong</creatorcontrib><creatorcontrib>Hu, Jiaping</creatorcontrib><creatorcontrib>Attah-Poku, Samuel</creatorcontrib><creatorcontrib>King, Martin</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biotechnology and applied biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Foldvari, Marianna</au><au>Baca-Estrada, Maria E.</au><au>He, Zhihong</au><au>Hu, Jiaping</au><au>Attah-Poku, Samuel</au><au>King, Martin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dermal and transdermal delivery of protein pharmaceuticals: lipid-based delivery systems for interferon α</atitle><jtitle>Biotechnology and applied biochemistry</jtitle><addtitle>Biotechnol Appl Biochem</addtitle><date>1999-10</date><risdate>1999</risdate><volume>30</volume><issue>2</issue><spage>129</spage><epage>137</epage><pages>129-137</pages><issn>0885-4513</issn><eissn>1470-8744</eissn><coden>BABIEC</coden><abstract>The dermal and transdermal delivery of protein pharmaceuticals faces enormous challenges, and at the same time has very significant potential for the non‐invasive treatment of both localized and systemic diseases. In this article we review the various approaches used to enhance and control the delivery of protein therapeutic agents through the dermal barrier. We show results of the delivery of interferon (IFN) α, an antiviral agent used in the treatment of condylomata acuminata (genital warts), using lipid‐based delivery systems (LBDS). In the general category of LBDS, we investigated the use of liposomes and fatty acylation as ways to increase IFNα delivery into human skin.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>10512792</pmid><doi>10.1111/j.1470-8744.1999.tb00903.x</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0885-4513
ispartof Biotechnology and applied biochemistry, 1999-10, Vol.30 (2), p.129-137
issn 0885-4513
1470-8744
language eng
recordid cdi_proquest_miscellaneous_70832888
source Wiley-Blackwell Read & Publish Collection
subjects a-Interferon
Acetylation
Administration, Cutaneous
Administration, Topical
Biological and medical sciences
Biotechnology
Drug Carriers
Drug Delivery Systems
Fundamental and applied biological sciences. Psychology
Health. Pharmaceutical industry
Humans
Industrial applications and implications. Economical aspects
Interferon-alpha - administration & dosage
Interferon-alpha - chemistry
Interferon-alpha - pharmacokinetics
Liposomes
Miscellaneous
Skin Absorption
title Dermal and transdermal delivery of protein pharmaceuticals: lipid-based delivery systems for interferon α
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T17%3A41%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dermal%20and%20transdermal%20delivery%20of%20protein%20pharmaceuticals:%20lipid-based%20delivery%20systems%20for%20interferon%20%CE%B1&rft.jtitle=Biotechnology%20and%20applied%20biochemistry&rft.au=Foldvari,%20Marianna&rft.date=1999-10&rft.volume=30&rft.issue=2&rft.spage=129&rft.epage=137&rft.pages=129-137&rft.issn=0885-4513&rft.eissn=1470-8744&rft.coden=BABIEC&rft_id=info:doi/10.1111/j.1470-8744.1999.tb00903.x&rft_dat=%3Cproquest_cross%3E17405084%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4683-48f1dedafb22446b82eae555848a15d969db037004922cf4517cfef1e562d7413%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17405084&rft_id=info:pmid/10512792&rfr_iscdi=true